Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 2/20 | 0.42 |
| ▸ | LTB4R2 | Q9NPC1 | 2/20 | 0.41 |
| ▸ | AGTR1 | P30556 | 12/20 | 0.39 |
| ▸ | MME | P08473 | 10/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.38 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.38 |
| ▸ | MLNR | O43193 | 2/20 | 0.36 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL840470 | 0.93 | LTB4R2 (0.43) | LTB4R2AGTR1MMEAGTR2 | |
| SCHEMBL839269 | 0.92 | AGTR1 (0.40) | LTB4R2AGTR1MME | |
| SCHEMBL839949 | 0.91 | AGTR1 (0.41) | LTB4R2AGTR1MME | |
| SCHEMBL859394 | 0.91 | AGTR1 (0.41) | LTB4R2AGTR1MME | |
| SCHEMBL839252 | 0.91 | AGTR1 (0.41) | LTB4R2AGTR1MME | |
| SCHEMBL839870 | 0.91 | AGTR1 (0.40) | LTB4R2AGTR1MMEHDAC1HDAC6 | |
| SCHEMBL840125 | 0.90 | AGTR1 (0.45) | LTB4R2AGTR1MME | |
| SCHEMBL839995 | 0.90 | AGTR1 (0.39) | AGTR1MME | |
| SCHEMBL841346 | 0.90 | AGTR1 (0.45) | LTB4R2AGTR1MME | |
| SCHEMBL839257 | 0.89 | AGTR1 (0.37) | LTB4R2AGTR1MMEAGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143298-B2 | Dual-acting antihypertensive agents | THERAVANCE, INC. (US) | 2012-03-27 | — | — | US | disclosed |